These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16729760)

  • 1. [Efficiency of includes of bioactive substances in diet of patient with hepatic encephalopathy].
    Kaziulin AN; Petukhov AB; Kucheriavyĭ IuA
    Vopr Pitan; 2006; 75(2):40-4. PubMed ID: 16729760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of hepatic encephalopathy using a modified high-calorie high-protein diet.
    Gheorghe L; Iacob R; Vădan R; Iacob S; Gheorghe C
    Rom J Gastroenterol; 2005 Sep; 14(3):231-8. PubMed ID: 16200232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of hepatic encephalopathy with oral zinc supplementation: a long-term treatment.
    Bresci G; Parisi G; Banti S
    Eur J Med; 1993; 2(7):414-6. PubMed ID: 8258031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Optimization of therapy in patients with hepatic cirrhosis and encephalopathy].
    Ivanov AG; Trusov VV
    Klin Med (Mosk); 2008; 86(6):62-6. PubMed ID: 18720715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of cirrhotic hepatic encephalopathy with L-dopa. A controlled trial.
    Michel H; Solere M; Granier P; Cauvet G; Bali JP; Pons F; Bellet-Hermann H
    Gastroenterology; 1980 Aug; 79(2):207-11. PubMed ID: 6995221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spatio-temporal decomposition of the electroencephalogram in patients with cirrhosis.
    Montagnese S; Jackson C; Morgan MY
    J Hepatol; 2007 Mar; 46(3):447-58. PubMed ID: 17239476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic effect of L-ornithine-L-aspartate on liver cirrhosis complicated by hepatic encephalopathy].
    Chen MF; Li RC; Chen CH; Gao XC
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):718-9, 722. PubMed ID: 15958319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of administration of Escherichia coli Nissle (Mutaflor) on intestinal colonisation, endo-toxemia, liver function and minimal hepatic encephalopathy in patients with liver cirrhosis].
    Lata J; Juránková J; Príbramská V; Fric P; Senkyrík M; Díte P; Kroupa R
    Vnitr Lek; 2006 Mar; 52(3):215-9. PubMed ID: 16722152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [An epidemiological survey of subclinical hepatic encephalopathy].
    Zeng Z; Li YY; Nie YQ
    Zhonghua Gan Zang Bing Za Zhi; 2003 Nov; 11(11):680-2. PubMed ID: 14636446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal protein diet for episodic hepatic encephalopathy: results of a randomized study.
    Córdoba J; López-Hellín J; Planas M; Sabín P; Sanpedro F; Castro F; Esteban R; Guardia J
    J Hepatol; 2004 Jul; 41(1):38-43. PubMed ID: 15246205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Event-related cerebral potentials for the diagnosis of subclinical hepatic encephalopathy in patients with liver cirrhosis.
    Ciećko-Michalska I; Senderecka M; Szewczyk J; Panasiuk A; Słowik A; Wyczesany M; Binder M; Mach T
    Adv Med Sci; 2006; 51():273-7. PubMed ID: 17357325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The response to combined therapy of hepatic encephalopathy in patients with hepatic cirrhosis].
    Maev IV; V'iuchnova ES; Lebedeva EG; Iakovenko EI; Dicheva DT
    Klin Med (Mosk); 2002; 80(5):42-5. PubMed ID: 12087887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P300 latency for the diagnosis of minimal hepatic encephalopathy: evidence that spectral EEG analysis and psychometric tests are enough.
    Amodio P; Valenti P; Del Piccolo F; Pellegrini A; Schiff S; Angeli P; Poci C; Mapelli D; Iannizzi P; Gatta A
    Dig Liver Dis; 2005 Nov; 37(11):861-8. PubMed ID: 16183341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis.
    Sharma P; Sharma BC; Sarin SK
    Liver Int; 2009 Oct; 29(9):1365-71. PubMed ID: 19555401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychometric tests and "latent" portal-systemic encephalopathy.
    Loguercio C; Del Vecchio-Blanco C; Coltorti M
    Br J Clin Pract; 1984; 38(11-12):407-11. PubMed ID: 6529543
    [No Abstract]   [Full Text] [Related]  

  • 16. L-ornithine-L-aspartate infusion efficacy in hepatic encephalopathy.
    Ahmad I; Khan AA; Alam A; Dilshad A; Butt AK; Shafqat F; Malik K; Sarwar S
    J Coll Physicians Surg Pak; 2008 Nov; 18(11):684-7. PubMed ID: 18983791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of the hepatic encephalopathy scoring algorithm in a clinical trial of patients with cirrhosis and severe hepatic encephalopathy.
    Hassanein T; Blei AT; Perry W; Hilsabeck R; Stange J; Larsen FS; Brown RS; Caldwell S; McGuire B; Nevens F; Fontana R
    Am J Gastroenterol; 2009 Jun; 104(6):1392-400. PubMed ID: 19455117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of neuropsychological testing and electroencephalogram for early detection of minimal hepatic encephalopathy].
    Choi CS; Kim BI; Lee MH; Choi HS; Kim SH; Ahn DH
    Korean J Hepatol; 2005 Dec; 11(4):329-38. PubMed ID: 16380662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy of acute and chronic hepatic encephalopathy in patients with liver cirrhosis].
    Ferenci P
    Z Gastroenterol; 1998 Oct; 36(10):909-16. PubMed ID: 9846370
    [No Abstract]   [Full Text] [Related]  

  • 20. Malnutrition and hypermetabolism are not risk factors for the presence of hepatic encephalopathy: a cross-sectional study.
    Sörös P; Böttcher J; Weissenborn K; Selberg O; Müller MJ
    J Gastroenterol Hepatol; 2008 Apr; 23(4):606-10. PubMed ID: 18005013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.